Cheiron Raises $8 Million Seed Round Led By Menlo Ventures For AI-Native Drug Development Platform
By Amit Chowdhry ● Today at 8:06 AM
Cheiron has raised $8 million in seed funding to develop an artificial intelligence-native operating system for managing drug development programs. The round was led by Menlo Ventures, with backing and strategic support from investors and industry leaders including Moderna co-founder and MIT Institute Professor Robert Langer, former Pfizer Chief Medical Officer Freda Lewis-Hall, Chai Discovery co-founder and CEO Josh Meier, and former Starbucks CEO Laxman Narasimhan.